Literature DB >> 8976279

The anatomy of the tunica albuginea in the normal penis and Peyronie's disease.

G Brock1, G L Hsu, L Nunes, B von Heyden, T F Lue.   

Abstract

PURPOSE: We studied the fine architecture of the tunica albuginea of the penis.
MATERIALS AND METHODS: The study included 6 human male cadavers and 10 surgical patients (5 with Peyronie's disease and 5 with normal penile anatomy).
RESULTS: The tunica albuginea of the corpora cavernosa is a bi-layered structure with multiple sub layers. Inner layer bundles support and contain the cavernous tissue and are oriented circularly. Radiating from this layer are intracavernous pillars acting as struts, which augment the septum and provide essential support to the erectile tissue. Outer layer bundles are oriented longitudinally. These fibers extend from the glans penis to the proximal crura, where they insert into the inferior pubic ramus. There are no outer layer fibers between the 5 and 7 o'clock positions. Elastic fibers normally form an irregularly latticed network on which collagen fibers rest. In Peyronie's disease the well ordered appearance of the collagen layers is lost: excessive deposits of collagen, disordered elastic fibers and fibrin are found within the region of the plaque.
CONCLUSIONS: The normal 3-dimensional structure of the tunica affords great flexibility, rigidity and tissue strength to the penis, which are lost consequent to structural changes in Peyronie's disease.

Entities:  

Mesh:

Year:  1997        PMID: 8976279

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

1.  Plaque incision and venous patch grafting for Peyronie's disease.

Authors:  Ahmet Metin; Onder Kayigil; S Iftekhar Ahmed
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 2.  Evolution in the concept of erection anatomy.

Authors:  Ayman Awad; Bayan Alsaid; Thomas Bessede; Stéphane Droupy; Gérard Benoît
Journal:  Surg Radiol Anat       Date:  2010-08-05       Impact factor: 1.246

3.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

4.  Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?

Authors:  Benjamin N Breyer; Alan W Shindel; Yun-Ching Huang; Michael L Eisenberg; Dana A Weiss; Tom F Lue; James F Smith
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

5.  Update on plication procedures for Peyronie's disease and other penile deformities.

Authors:  Elizabeth M Mobley; Molly E Fuchs; Jeremy B Myers; William O Brant
Journal:  Ther Adv Urol       Date:  2012-12

6.  Office ultrasound for the urologist.

Authors:  Etai Goldenberg; Bruce R Gilbert
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

7.  Normal penile, scrotal, and perineal anatomy with reconstructive considerations.

Authors:  Moira E Dwyer; Christopher J Salgado; Deborah J Lightner
Journal:  Semin Plast Surg       Date:  2011-08       Impact factor: 2.314

8.  Penile intracavernosal pillars: lessons from anatomy and potential implications for penile prosthesis placement.

Authors:  M J Pagano; A C Weinberg; C M Deibert; K Hernandez; J Alukal; L Zhao; S K Wilson; P H Egydio; R J Valenzuela
Journal:  Int J Impot Res       Date:  2016-04-07       Impact factor: 2.896

9.  Surgical treatment of Peyronie's disease with small intestinal submucosa graft patch.

Authors:  M Cosentino; A Kanashiro; A Vives; J Sanchez; M F Peraza; D Moreno; J Perona; V De Marco; E Ruiz-Castañe; J Sarquella
Journal:  Int J Impot Res       Date:  2016-03-31       Impact factor: 2.896

10.  Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.

Authors:  Fabio Castiglione; Petter Hedlund; Frank Van der Aa; Trinity J Bivalacqua; Patrizio Rigatti; Hein Van Poppel; Francesco Montorsi; Dirk De Ridder; Maarten Albersen
Journal:  Eur Urol       Date:  2012-09-24       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.